- Report
- February 2023
- 48 Pages
Global
From €3593EUR$3,995USD£3,165GBP
- Report
- February 2023
- 59 Pages
Global
From €3593EUR$3,995USD£3,165GBP
- Report
- November 2022
- 119 Pages
Global
From €3553EUR$3,950USD£3,129GBP
- Report
- November 2022
- 107 Pages
Global
From €3553EUR$3,950USD£3,129GBP
- Report
- October 2022
- 60 Pages
Global
From €3143EUR$3,495USD£2,769GBP
- Report
- July 2022
- 59 Pages
Global
From €3143EUR$3,495USD£2,769GBP
- Report
- November 2021
- 108 Pages
Global
From €13486EUR$14,995USD£11,879GBP
- Report
- February 2020
- 163 Pages
Global
From €13486EUR$14,995USD£11,879GBP
- Report
- July 2019
- 31 Pages
Global
From €3593EUR$3,995USD£3,165GBP
- Report
- November 2025
United Kingdom
From €1884EUR$2,095USD£1,660GBP
€3589EUR$3,990USD£3,161GBP
- Report
- February 2024
- 104 Pages
Global
From €3500EUR$4,169USD£3,191GBP
- Report
- November 2023
- 83 Pages
Global
From €3500EUR$4,169USD£3,191GBP
- Report
- October 2023
- 73 Pages
Global
From €3500EUR$4,169USD£3,191GBP
- Report
- December 2023
- 241 Pages
Global
€4492EUR$4,995USD£3,957GBP
- Report
- September 2024
- 150 Pages
Global
From €3463EUR$3,850USD£3,050GBP
€4362EUR$4,850USD£3,842GBP
- Report
- August 2024
- 150 Pages
Global
From €3463EUR$3,850USD£3,050GBP
€4362EUR$4,850USD£3,842GBP
- Report
- September 2024
- 112 Pages
Global
From €3598EUR$4,000USD£3,169GBP
- Report
- May 2024
- 75 Pages
Global
From €8989EUR$9,995USD£7,918GBP
- Report
- February 2024
- 226 Pages
Global
From €3598EUR$4,000USD£3,169GBP
- Report
- February 2024
- 79 Pages
Global
From €8989EUR$9,995USD£7,918GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more